Takeda Pharmaceutical

Summary

In 1781 was created Takeda Pharmaceutical, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Osaka. The company was established in Asia in Japan.

This organization was formed by Chobei Takeda I.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. When startup sums 3 of the founder, the probability for it to get the investment is little. Among the various public portfolio startups of the fund, we may underline Outpost Medicine, BioNumerik Pharmaceuticals, Molecular Templates Among the most popular fund investment industries, there are Therapeutics, Health Care. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The fund is generally included in less than 2 deals every year. This Takeda Pharmaceutical works on 9 percentage points more the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2017. The high activity for fund was in 2016. The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this Corporate Investor is 18 percentage points more often commits exit comparing to other companies.

The standard case for the fund is to invest in rounds with 3 partakers. Despite the Takeda Pharmaceutical, startups are often financed by F-Prime Capital, New Enterprise Associates, Sante Ventures. The meaningful sponsors for the fund in investment in the same round are SMBC Venture Capital, Mitsubishi UFJ Capital, Wellington Management. In the next rounds fund is usually obtained by Takeda Ventures, Adams Street Partners, Logos Capital.